T80.310
ABO incompatibility with acute hemolytic transfusion reaction
Clinical Classification Guidelines
Inclusion Terms
- ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion
- Acute hemolytic transfusion reaction (AHTR) due to ABO incompatibility
Medical Intelligence & Overview
ABO incompatibility with an acute hemolytic transfusion reaction (AHTR) is a serious complication that can occur during blood transfusions. It happens when the immune system attacks transfused blood cells that do not match the recipient’s ABO blood type, often resulting in rapid and potentially life-threatening reactions within 24 hours of the transfusion. Recognizing the causes, symptoms, and treatment options is crucial for better management and prevention of this condition.
Causes & Symptoms
Clinical Causes: Receiving blood of incompatible ABO type during transfusion Errors in blood typing or crossmatching procedures Mislabeled blood samples Emergency transfusions performed without proper blood type verification Miscommunication between healthcare personnel regarding patient blood type
Key Symptoms: Fever and chills Back pain and flank discomfort Dark urine or Hemoglobinuria Dizziness or feeling faint Rapid onset of chest pain or difficulty breathing Swelling and redness at the transfusion site Feeling of apprehension or anxiety Hypotension or low blood pressure Nausea or vomiting
Diagnostic & Treatment
Diagnosis Path: Diagnosis of an ABO incompatibility-induced hemolytic transfusion reaction involves a combination of clinical assessment and laboratory testing. Healthcare providers typically perform:
Treatment Protocols: Managing an acute hemolytic transfusion reaction focuses on stabilizing the patient and stopping the transfusion promptly. The treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is T80.310 a billable ICD-10 code?
Yes, T80.310 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.310?
Clinical documentation must specify the nature of ABO incompatibility with acute hemolytic transfusion reaction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference